The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer

被引:1
作者
Behling-Hess, Caroline [1 ]
Simonson, Grant [2 ]
Salz, Talya [3 ]
Fleege, Nicole [4 ]
Zylla, Dylan [5 ]
机构
[1] Univ Minnesota, Med Sch, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA
[4] Univ Iowa Hosp & Clin, Dept Internal Med, Div Hematol Oncol, IOWA CITY, IA USA
[5] HealthPartners Inst, Canc Res Ctr, Minneapolis, MN USA
关键词
Cannabis; Marijuana; Immune system; Cancer; Immune checkpoint inhibitors; C-REACTIVE PROTEIN; MEDIATED-IMMUNITY; CROHNS-DISEASE; INDIVIDUALS; CYTOKINE; IMMUNODEFICIENCY; LYMPHOCYTES; MODULATION;
D O I
10.1007/s00520-025-09218-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeCannabis is commonly used among patients with cancer for palliative benefit. As the use of immune checkpoint inhibitors (ICIs) for cancer therapy increases, there is concern about potential interactions between ICIs and cannabis. Preclinical studies suggest that cannabis leads to immunosuppression, which could impair the function of ICIs. However, only a few clinical studies have investigated this relationship. The goal of this review is to synthesize reported immunomodulatory effects of cannabis in patients with and without cancer in order to better understand whether these preclinical findings translate to the clinical space.MethodsA database search was conducted through Ovid Medline to identify relevant articles. Clinical studies investigating cannabis use in humans and the immune system were included. Preclinical studies and case studies were excluded. Information pertaining to immune changes with cannabis exposure was abstracted.ResultsForty studies met inclusion criteria, including 9 randomized, placebo-controlled clinical trials. Analysis of immune-related markers demonstrated no change in cytokines, T-cell counts, and CRP in most studies with cannabis exposure. Among patients with autoimmune diseases, cannabis use showed improvements in clinical symptoms even while objective laboratory immune markers remained unchanged.ConclusionWe did not find evidence of meaningful changes in immune parameters with cannabis use in the clinical setting across multiple diseases. In particular, immune markers relevant to ICI function did not appear to be associated with cannabis use. This evidence may provide some reassurance to patients and oncologists contemplating concomitant cannabis use with ICIs; however, additional well-controlled prospective studies are warranted in this setting.
引用
收藏
页数:9
相关论文
共 50 条
[31]   A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety [J].
Grant Steele ;
Tom Arneson ;
Dylan Zylla .
Current Oncology Reports, 2019, 21
[32]   Effects of Perioperative Cannabis Use on Bariatric Surgical Outcomes: a Systematic Review [J].
Jung, Flora ;
Lee, Yung ;
Manzoor, Saba ;
Hong, Dennis ;
Doumouras, Aristithes G. .
OBESITY SURGERY, 2021, 31 (01) :299-306
[33]   Cannabis Use in Patients With Cancer: A Clinical Review [J].
Worster, Brooke ;
Hajjar, Emily R. ;
Handley, Nathan .
JCO ONCOLOGY PRACTICE, 2022, 18 (11) :743-+
[34]   Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis [J].
Wallwork, Rachel S. ;
Kotzin, Jonathan J. ;
Cappelli, Laura C. ;
Mecoli, Christopher ;
Bingham III, Clifton O. ;
Wigley, Fredrick M. ;
Wilson, Parker C. ;
DiRenzo, Dana ;
Shah, Ami A. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 67
[35]   The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge-A Systematic Review [J].
Perdyan, Adrian ;
Sobocki, Bartosz Kamil ;
Balihodzic, Amar ;
Dabrowska, Anna ;
Kacperczyk, Justyna ;
Rutkowski, Jacek .
CANCERS, 2023, 15 (13)
[36]   Impact of Cannabis Use on Immune Cell Populations and the Viral Reservoir in People With HIV on Suppressive Antiretroviral Therapy [J].
Falcinelli, Shane D. ;
Cooper-Volkheimer, Alicia D. ;
Semenova, Lesia ;
Wu, Ethan ;
Richardson, Alexander ;
Ashokkumar, Manickam ;
Margolis, David M. ;
Archin, Nancie M. ;
Rudin, Cynthia D. ;
Murdoch, David ;
Browne, Edward P. .
JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (11) :1600-1609
[37]   Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review [J].
Collins, Michael ;
Soularue, Emilie ;
Marthey, Lysiane ;
Carbonnel, Franck .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) :1393-+
[38]   A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders [J].
Athanassiou, Maria ;
Dumais, Alexandre ;
Gnanhoue, Gismonde ;
Abdel-Baki, Amal ;
Jutras-Aswad, Didier ;
Potvin, Stephane .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (07) :779-791
[39]   Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid [J].
Said, Jordan T. ;
Talia, Jordan ;
Wei, Erin ;
Mostaghimi, Arash ;
Semenov, Yevgeniy ;
Giobbie- Hurder, Anita ;
Chen, Steven T. ;
LeBoeuf, Nicole R. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) :670-671
[40]   Impact of Immune Checkpoint Inhibitor Therapy on Quality of Life in Patients With Advanced Melanoma [J].
Jackson-Carroll, Natalie ;
Whisenant, Meagan ;
Crane, Stacey ;
Johnson, Constance .
CANCER NURSING, 2025, 48 (04) :261-279